The 2026 AAD Annual Meeting gave parents of teens with acne a clear message: pediatric acne and rosacea differ from adult disease and need early, individualized treatment. Pediatric acne means breakouts in children and teens, while rosacea means persistent facial redness with acne-like bumps. The meeting took place March 27-31, 2026 in Denver, Colorado, and covered medical, surgical, pediatric and cosmetic dermatology with late-breaking data, according to the Dermatology Times meetings calendar. Pediatric care was a featured part of the program, not a side topic.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why teen acne and rosacea need their own plan
- What current guidelines strongly support
- Antibiotics, inflammation and narrower options
- What should parents ask at the visit?
Why teen acne and rosacea need their own plan
Board-certified dermatologist Dawn Eichenfield, MD, FAAD, PhD of Rady Children's Hospital-San Diego and UC San Diego discussed how pediatric cases differ from adult disease, according to AAD official meeting highlights. Her message was that age, skin sensitivity and growth matter when choosing treatment.
That means a teen should not simply borrow an adult routine. Dose, vehicle and irritation risk can change what works for younger skin. Early care can also limit scarring, lingering marks and emotional stress.
What current guidelines strongly support
Current AAD acne vulgaris guidelines were updated in 2024 and published in the Journal of the American Academy of Dermatology. They give strong recommendations to topical benzoyl peroxide, retinoids, antibiotics, fixed-dose combinations and oral isotretinoin for severe disease, as reported by the Academy via MedicalXpress.
Fixed-dose combinations put two actives in one product, such as retinoid plus benzoyl peroxide. Fewer tubes can mean simpler routines and better daily use. Parents can ask whether a combination fits their teen's severity and skin tolerance.
Antibiotics, inflammation and narrower options
A dedicated Acne and Rosacea session on March 27, 2026 framed antibiotics as anti-inflammatory rather than antimicrobial, according to the HCPLive 2026 AAD preview. The focus was stewardship and narrow-spectrum sarecycline to preserve gut microbiome while retaining efficacy.
That distinction matters for parents worried about long antibiotic courses. The goal is calming inflammation with the shortest effective course. At AAD 2026, Almirall presented pooled Phase 3 evaluations of sarecycline alongside broader dermatology posters.
What should parents ask at the visit?
Follow-up after oral isotretinoin varies widely among prescribers. A practitioner survey presented at AAD 2026 found highly variable follow-up and maintenance, so parents should not assume one standard relapse-prevention path. Use the visit to clarify the full course, including topicals and return triggers:.
- Ask about a combination topical and a maintenance plan after isotretinoin.
- Ask about cost-effective choices such as fixed-dose topicals.
- For teen girls, ask whether spironolactone or combined oral contraceptives may fit, since AAD 2026 research interviews highlighted both for female acne.
You Might Also Like
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Scarring and Pigment-Change Questions for Parents of Teens With Acne
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: How Parents of Teens With Acne Can Read the Conference Headline Carefully
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Pharmacy and Prescriber Questions for Parents of Teens With Severe Acne